...
首页> 外文期刊>Human vaccines & immunotherapeutics. >Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice
【24h】

Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice

机译:重组BCG分泌抗原85B / Rv3425融合蛋白对小鼠结核分枝杆菌感染的保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, the protective efficacy of a novel recombinant BCG strain co-expressing Ag85B and Rv3425 against Mycobacterium tuberculosis H37Rv was evaluated in mice. This rBCG::Ag85B-Rv3425 strain could provide similar or even better protective efficacy against M. tuberculosis challenge compared with BCG, as shown by no weight loss, significantly reduced lung:body weight ratios and lung bacteria load only at early time of infection. The results suggest that rBCG::Ag85B-Rv3425 could be a potential tuberculosis vaccine candidate for further study.
机译:在这项研究中,评估了小鼠中共表达Ag85B和Rv3425的新型重组BCG菌株对结核分枝杆菌H37Rv的保护作用。该rBCG :: Ag85B-Rv3425菌株与BCG相比,可提供与结核分枝杆菌挑战相似或什至更好的保护功效,如无体重减轻,仅在感染初期显着降低肺:体重比和肺细菌负荷。结果表明,rBCG :: Ag85B-Rv3425可能是潜在的结核病疫苗候选者,需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号